4//SEC Filing
Aggarwal Sumit 4
Accession 0001104659-23-007511
CIK 0001035354other
Filed
Jan 26, 7:00 PM ET
Accepted
Jan 27, 4:04 PM ET
Size
6.0 KB
Accession
0001104659-23-007511
Insider Transaction Report
Form 4
Aggarwal Sumit
Director
Transactions
- Award
Stock Options (Right to Buy)
2023-01-25+68,700→ 68,700 totalExercise: $4.27Exp: 2033-01-25→ Common Stock (68,700 underlying)
Footnotes (1)
- [F1]The option vests and becomes exercisable as to 25% of the underlying shares on the first anniversary of January 25, 2023, and the remaining 75% of the underlying shares vest in 12 equal quarterly installments thereafter, subject to the Reporting Person's continuous service to the Issuer through the applicable vesting date.
Documents
Issuer
Eloxx Pharmaceuticals, Inc.
CIK 0001035354
Entity typeother
Related Parties
1- filerCIK 0001854362
Filing Metadata
- Form type
- 4
- Filed
- Jan 26, 7:00 PM ET
- Accepted
- Jan 27, 4:04 PM ET
- Size
- 6.0 KB